Human alpha cell transcriptomic signatures of types 1 and 2 diabetes highlight disease-specific dysfunction pathways

• Published in: iScience Vol. 25; no. 10; p. 105056
• Main Authors: Bosi, Emanuele, Marchetti, Piero, Rutter, Guy Allen, Eizirik, Decio Laks
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 21.10.2022; Elsevier
• Subjects: bioinformatics; Biological sciences; transcriptomics; transcriptomics; Biological sciences; bioinformatics
• ISSN: 2589-0042; 2589-0042
• DOI: 10.1016/j.isci.2022.105056

Although glucagon secretion is perturbed in both T1D and T2D, the pathophysiological changes in individual pancreatic alpha cells are still obscure. Using recently curated single-cell RNASeq data from T1D or T2D donors and their controls, we identified alpha cell transcriptomic alterations consistent with both common and discrete pathways. Although alterations in alpha cell identity gene (ARX, MAFB) expression were conserved, cytokine-regulated genes and genes involved in glucagon biosynthesis and processing were up-regulated in T1D. Conversely, mitochondrial genes associated with ROS (COX7B, NQO2) were dysregulated in T2D. Additionally, T1D alpha cells displayed altered expression of autoimmune-induced ER stress genes (ERLEC1, HSP90), whilst those from T2D subjects showed modified glycolytic and citrate cycle gene (LDHA?, PDHB, PDK4) expression. Thus, despite conserved alterations related to loss of function, alpha cells display disease-specific gene signatures which may be secondary to the main pathogenic events in each disease, namely immune- or metabolism-mediated-stress, in T1D and T2D, respectively. [Display omitted] •Transcriptomic profiles of alpha cells display differences between T1D and T2D•Dysregulation of some alpha cell identity genes was found in both conditions•In T1D alpha cells displayed signatures of increased ER stress•T2D alpha cells show increased ROS defense and depression of central metabolism Biological sciences; Bioinformatics; Transcriptomics.